Stéphane Bancel

$2.7B
as of 10/04/24

About Stéphane Bancel

Stephane Bancel is the CEO of Cambridge, Massachusetts-based biotech firm Moderna, known for its Covid-19 vaccine.

He became CEO of Moderna in 2011 and owns a roughly 8% stake in the publicly traded company.

Before joining Moderna, Bancel was the CEO of French diagnostics company BioM?rieux, founded by fellow French billionaire Alain M?rieux.

Moderna's Covid-19 vaccine was granted full FDA approval in January 2022; it had previously received emergency-use authorization in December 2020.

Moderna was founded in 2010 and went public in December 2018; the company develops drugs and vaccines using messenger RNA.

Personal stats

Citizenship

France

Source of wealth

Biotech, vaccines

Residence

Boston, Massachusetts

Marital status

Married

Birth date

07/20/72 (age 52)

Number of children

2

Education

Master of Science in Engineering, Ecole Centrale Paris; Master of Business Administration, Harvard University; Master of Science in Engineering, University of Minnesota

Self-made

self-made

Stéphane Bancel’s fortune is worth

45K

troy ounces of gold

41K

median U.S. household

27K

median U.S. income

0.054%

U.S. credit card volume

0.011%

GDP of the United States

0.008%

United States debt

Net worth history

Annual ranking

Net worth over time

Real-time ranking

Financial assets

NASDAQ | MRNA-US

Moderna, Inc.

NASDAQ | MRNA-US

Moderna, Inc.

NASDAQ | MRNA-US

Moderna, Inc.

NASDAQ | MRNA-US

Moderna, Inc.

NASDAQ | MRNA-US

Moderna, Inc.

NASDAQ | MRNA-US

Moderna, Inc.

NASDAQ | MRNA-US

Moderna, Inc.

Images © Forbes.com. All rights reserved.